CarsonAllaria Wealth Management’s Pacific Biosciences PACB Stock Holding History

CarsonAllaria Wealth Management’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-198	Closed	-$1.65K	–	374
2023 Q3	$1.65K	Hold	198	–	–	﹤0.01%	312
2023 Q2	$2.63K	Hold	198	–	–	﹤0.01%	300
2023 Q1	$2.29K	Hold	198	–	–	﹤0.01%	293
2022 Q4	$2K	Hold	198	–	–	﹤0.01%	287
2022 Q3	$1K	Hold	198	–	–	﹤0.01%	319
2022 Q2	$1K	Buy	198 +73	+58%	+$444	﹤0.01%	315
2022 Q1	$1K	Sell	125 -73	-37%	-$840	﹤0.01%	326
2021 Q4	$4K	Buy	+198	New	+$4.78K	﹤0.01%	287

Other funds holding PACB

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

CarsonAllaria Wealth Management's PACB Position: Q4 2023 in Review

CarsonAllaria Wealth Management sold out of Pacific Biosciences (PACB) in Q4 2023, closing a stake of 198 shares — an estimated $1.65K sold.

CarsonAllaria Wealth Management first reported a position in PACB in Q4 2021 and held it in 8 quarters. The position peaked at $4K in Q4 2021. 274 funds tracked by Wall St. Rank hold PACB as of Q4 2023.

CarsonAllaria Wealth Management reported no remaining Pacific Biosciences position as of Q4 2023 after selling out during the quarter.
CarsonAllaria Wealth Management sold 198 Pacific Biosciences shares in Q4 2023, an estimated $1.65K.
CarsonAllaria Wealth Management first reported a position in Pacific Biosciences in Q4 2021 and held it in 8 quarters.
CarsonAllaria Wealth Management's Pacific Biosciences position peaked at $4K in Q4 2021.
274 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2023.

Based on CarsonAllaria Wealth Management's 13F filing for Q4 2023, filed 8 Feb 2024.